Inflammation of the gastrointestinal tract is a complex biological response to harm caused by bacteria, damaged cells, or irritants. The symbiotic microbiome in the digestive tract is thought to protect the gut by eliminating unwanted stimuli and promoting recovery. The presence or lack of a microbiome can cause type 2 immunity to be worsened, as well as allergic/infectious and inflammatory consequences, including parasitic diseases. Inflammation of the gastrointestinal tract is frequently accompanied by changes in vascular anatomy and function. Microvascular congestion, Dilatation of the arteries supplying the tissue, and excessive fluid and protein leakage with interstitial oedema are examples of these disorders. IBD medications can often reduce inflammation and improve intestinal healing, leading in remission—long-term symptom relief. Many persons with IBD, however, have a chronic illness that requires lifelong therapy.
Title : Gastroenterology viewed through a glass darkly: An IDI perspective
Gilles R G Monif, University of Florida, United States
Title : The psychology of disorders of gut-brain interactions
Tracy E Hill, Ph.D. & Associates LLC, United States
Title : How epigastric impedance would radically change gastric medicine
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Role of Pregnancy (P) and breastfeeding on Gallstones (GS) related Acute Pancreatitis (AP)
Alberto Maringhini, La Maddalena, Italy
Title : From the birth of atoms to life: Iodine and caesium, angels and demons of evolutionary biology, in pancreatic cancer and diabetes
Venturi Sebastiano, AUSL-ROMAGNA, Italy
Title : The IL17REL gene encodes a decoy receptor of IL-17 family cytokines to control gut inflammation
Youcun Qian, Shanghai Institute of Nutrition and Health, China